CareDx Inc. (CDNA)

9.47 +0.12 (+1.283%)

IEX Real-Time Price

April 25, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 9.35

Price Open 9.38

Volume: 233,544

Avg Volume: 505,229

Market Cap: 275.34M

P/E Ratio -11.69

52 Wk Range 0.76-9.51



CDNA Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-03-29
27.28M
1.16M
2.46
4.27%

2018-03-15
27.37M
5.39M
38.87
19.68%

2018-02-28
26.9M
5.1M
32.90
18.97%

2018-02-15
26.9M
4.87M
23.43
18.11%




CDNA Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-06-08
Q1 2018
N/A
-0.14 (2)
0.00
0.00

2018-05-10
Q1 2018
AMC
-0.13 (1)
0.00
0.00

2018-04-20
Q4 2017
N/A
-0.15 (3)
-0.11
0.05

2018-03-22
Q4 2017
AMC
-0.15 (3)
-0.11
0.05

News

Midday Gainers / Losers (3/23/2018) (2018-03-23 12:53 SeekingAlpha)

Gainers: NFEC +43% . DSS +32% . INNT +25% . NWY +25% . BGI +25% . CDNA +21% . HOME +19% . IFMK +18% . CALI +15% . SGH +14% . ABAC +14% . More news on: NF Energy Saving Corp., Document Security Systems, Inc, Innovate Biopharmaceuticals, Inc., Stocks on th…

 

CareDx's (CDNA) CEO Peter Maag on Q4 2017 Results - Earnings Call Transcript (2018-03-22 21:43 SeekingAlpha)

CareDx, Inc. (CDNA) Q4 2017 Results Earnings Conference Call March 22, 2018 04:30 PM ET Executives David Clair - IR Peter Maag - President and CEO Michael Bell - CFO Analysts Kevin Ellich - Craig-Hallum Bill Quirk - Piper Jaffray Nicholas Jansen - Raymond James Prese…

 

CareDx Q4 top line up 15%; profitability expected in H2 2018 (2018-03-22 16:10 SeekingAlpha)

CareDx (NASDAQ: CDNA ) Q4 results ($M): Revenue: 12.5 (+14.7%); Testing: 8.6 (+17.1%); Product: 3.7 (+6.6%). More news on: CareDx, Healthcare stocks news, Earnings news and commentary, , Read more …

 

CareDx beats by $0.05, beats on revenue (2018-03-22 16:02 SeekingAlpha)

CareDx (NASDAQ: CDNA ): Q4 EPS of -$0.09 beats by $0.05 . More news on: CareDx, Earnings news and commentary, Consumer stocks news, , Read more …

 

CareDx secures as much as $35M in new capital (2018-03-01 09:02 SeekingAlpha)

CareDx (NASDAQ: CDNA ) inks a binding commitment with Perceptive Advisors for a term loan of $15M - 35M. Funding will happen in mid-April. The loan will bear interest of 10.5% and will have an interest-only period of three years. More news on: CareDx, Healthcare stocks news, Read mor…

 


Statistics

Shares Outstanding: 29.07M

Top 15 Institution Percent: 72.00

Price To Sales: 7.48

Price To Book: 13.63

Revenue: 35.82M

Gross Profit: 20.04M

Cash: 27.27M

Debt: 102.56M

Return On Assets: -64.84

Return On Equity: -689.48

Profit Margin: N/A

Price History

Beta: 0.28

50-day Moving Avg: 6.96

200-day Moving Avg: 5.20

YTD Change: 34.33

5-day Change: 5.34

1-month Change: 19.87

3-month Change: 58.89

6-month Change: 66.14

1-year Change: N/A

Revenue Per Share: 1.00

Revenue Per Employee: 200117.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: CareDx Inc.

Exchange: NASDAQ Global Market

Industry: Medical Diagnostics & Research

Sector: Healthcare

Website: http://www.xdx.com

CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.